RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
RP5063, a novel, multimodal, serotonin receptor modulator, prevents monocrotaline-induced pulmonary arterial hypertension in rats
Authors
Keywords
Pulmonary arterial hypertension, RP5063, 5-hydroxytryptamine 2B receptor, Rat monocrotaline model, Anti-proliferative, Vascular remodeling
Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 810, Issue -, Pages 92-99
Publisher
Elsevier BV
Online
2017-06-01
DOI
10.1016/j.ejphar.2017.05.048

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.